Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) EBITDA (2018 - 2025)

Historic EBITDA for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $5.6 million.

  • Viemed Healthcare's EBITDA rose 24.88% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 4681.65%. This contributed to the annual value of $11.3 million for FY2024, which is 997.75% up from last year.
  • Latest data reveals that Viemed Healthcare reported EBITDA of $5.6 million as of Q3 2025, which was up 24.88% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's EBITDA registered a high of $6.5 million during Q4 2024, and its lowest value of $1.0 million during Q2 2022.
  • Its 5-year average for EBITDA is $3.0 million, with a median of $2.4 million in 2022.
  • As far as peak fluctuations go, Viemed Healthcare's EBITDA tumbled by 9195.0% in 2021, and later skyrocketed by 15012.85% in 2023.
  • Quarter analysis of 5 years shows Viemed Healthcare's EBITDA stood at $4.1 million in 2021, then plummeted by 42.45% to $2.4 million in 2022, then soared by 45.97% to $3.5 million in 2023, then surged by 85.56% to $6.5 million in 2024, then decreased by 12.55% to $5.6 million in 2025.
  • Its EBITDA stands at $5.6 million for Q3 2025, versus $5.1 million for Q2 2025 and $3.8 million for Q1 2025.